Ek Tek Moxipet K (5ml) is a prescription-strength, dual-action veterinary ophthalmic solution engineered to treat complicated superficial bacterial eye infections accompanied by acute tissue inflammation, swelling, and localized pain in dogs and cats. The advanced therapeutic formula combines a potent fourth-generation fluoroquinolone antibiotic with a high-performance non-steroidal anti-inflammatory drug (NSAID): Moxifloxacin Hydrochloride (0.5% w/v) and Ketorolac Tromethamine (0.5% w/v), sterilely prepared in an aqueous buffered vehicle.

Each active pharmaceutical ingredient is precisely paired to deliver immediate comfort and eliminate micro-bacterial pressure. Moxifloxacin provides rapid, broad-spectrum bactericidal action against tricky Gram-positive and Gram-negative bacteria by inhibiting essential enzymes (DNA gyrase and topoisomerase IV) required for bacterial DNA replication. Ketorolac Tromethamine acts as a localized NSAID that safely blocks prostaglandin synthesis, providing direct relief from burning, severe conjunctival swelling, and deep eye discomfort without the corneal-thinning or systemic side effects associated with corticosteroid drops. In companion animal medicine, Moxipet K is highly effective for managing severe bacterial conjunctivitis (pink eye), bacterial keratitis, and corneal abrasions. It is also an essential clinical tool for post-operative management to prevent infections and reduce pain following delicate intraocular procedures (such as cataract removal).

Critical Safety Contraindication: Combination antibiotic-NSAID eye drops like Moxipet K are strictly contraindicated in cases of deep, active, or melting corneal ulcers. Ketorolac can delay corneal cell regeneration (re-epithelialization) and mask escalating pain signals that would otherwise alert a pet parent to a worsening ulcer. A veterinarian must always perform a fluorescein stain test to confirm the cornea is completely intact before this medication is introduced.